help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cuneo, R. C.
Right arrow Articles by Gilchrist, N. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cuneo, R. C.
Right arrow Articles by Gilchrist, N. L.

Journal of Clinical Endocrinology & Metabolism, Vol 63, 946-953, Copyright © 1986 by Endocrine Society


ARTICLES

Renal, hemodynamic, and hormonal responses to atrial natriuretic peptide infusions in normal man, and effect of sodium intake

RC Cuneo, EA Espiner, MG Nicholls, TG Yandle, SL Joyce and NL Gilchrist

The effect of 60-min constant iv infusions of alpha-human atrial natriuretic peptide (alpha hANP; 200 micrograms), sufficient to increase the steady state venous plasma alpha hANP concentration to levels found in patients with some circulatory disorders, was studied in six normal men equilibrated on a high sodium diet (200 mmol daily) and again when equilibrated on a low sodium intake (10 mmol daily). In each instance, the responses to alpha hANP were compared to those to control infusions given on the preceding day. The mean steady state plasma immunoreactive ANP concentration during the infusions was 320 pmol/liter and was the same during both diets. Thus, the MCR of alpha hANP was unaffected by major changes in sodium intake. Compared to control day observations, infusions of alpha hANP induced a more than 3- fold increase in sodium excretion and at least a 2-fold increase in urine volume and calcium and magnesium excretion in subjects ingesting 200 mmol sodium daily. During the low sodium diet, alpha hANP was still diuretic and induced comparable magnesium excretion, but the natriuresis was only 11% of that during the high salt diet. No significant changes in blood pressure or heart rate occurred during alpha hANP infusions during either diet, although during both diets there was a significant rise in plasma norepinephrine (P less than 0.02), which persisted well beyond the disappearance of immunoreactive ANP from plasma. Despite this sympathetic activation, renin and aldosterone production was reduced by alpha hANP. During low salt intake, alpha hANP significantly decreased PRA (mean pretreatment, 1.79; posttreatment, 1.25 nmol/liter/h; P less than 0.03), angiotensin II (mean pretreatment, 49; posttreatment, 28 pmol/liter; P less than 0.008), and plasma aldosterone (mean pretreatment, 554; posttreatment 307 pmol/liter; P less than 0.007), whereas values during control infusions did not change. Similar percent decreases in PRA and aldosterone also occurred during the high salt diet. Plasma cortisol and arginine vasopressin did not change during the alpha hANP infusions on either diet. We conclude that steady state levels of alpha hANP in plasma, similar to those in patients with some circulatory disorders, significantly increase sodium excretion and inhibit all elements of the renin-angiotensin-aldosterone system. The natriuretic, but not the hormonal or chronotropic, effects of alpha hANP are reduced by sodium depletion in normal man.


This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
X.-P. Ni, A. Bhargava, D. Pearce, and M. H. Humphreys
Modulation by dietary sodium intake of melanocortin 3 receptor mRNA and protein abundance in the rat kidney
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R560 - R567.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Schmitt, A. Qasem, C. McEniery, I. B. Wilkinson, V. Tatarinoff, K. Noble, J. Klemes, N. Payne, M. P. Frenneaux, J. Cockcroft, et al.
Role of natriuretic peptides in regulation of conduit artery distensibility
Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1167 - H1171.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
S. I. McFarlane, N. Winer, and J. R. Sowers
Role of the Natriuretic Peptide System in Cardiorenal Protection
Arch Intern Med, December 8, 2003; 163(22): 2696 - 2704.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Schmitt, A. J.M. Broadley, A. K. Nightingale, N. Payne, P. Gunaruwan, J. Taylor, L. Lee, J. Cockcroft, A. D. Struthers, and M. P. Frenneaux
Atrial Natriuretic Peptide Regulates Regional Vascular Volume and Venous Tone in Humans
Arterioscler. Thromb. Vasc. Biol., October 1, 2003; 23(10): 1833 - 1838.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
R. Gasser, O. Luha, J. Dusleag, B. Eber, R. Rotman, W. Klein, and G.R. Fueger
Observations on Plasma ANP Levels During Short-Term Transient Myocardial Ischemia Produced by PTCA in Patients with LAD Stenosis
Angiology, April 1, 1993; 44(4): 278 - 288.
[Abstract] [PDF]


Home page
VASC ENDOVASCULAR SURGHome page
M. Pac, A. Ates, H. Kocak, M.R. Yigitoglu, and I. Yekeler
The Atrial Natriuretic Peptide and Its Relation to Hemodynamic and Laboratory Values in Mitral Valve and Coronary Surgery
Vascular and Endovascular Surgery, March 1, 1992; 26(2): 109 - 115.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1986 by The Endocrine Society